• 1. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 2. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 3. Achieving crystal-induced room temperature phosphorescence and reversible photochromic properties by strong intermolecular interactions?
  Fuming Xiao,Mengzhu Wang,Yunxiang Lei,Wenbo Dai,Yunbing Zhou,Miaochang Liu,Wenxia Gao,Xiaobo Huang,Huayue Wu J. Mater. Chem. C, 2020,8, 17410-17416
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An assay for the enzyme N-acetyl-β-d-glucosaminidase (NAGase) based on electrochemical detection using screen-printed carbon electrodes (SPCEs)
  R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871

2,5-Difluoromandelic Acid (CAS No. 207853-61-0): A Comprehensive Overview

2,5-Difluoromandelic acid (CAS No. 207853-61-0) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique molecular structure, holds potential applications in various therapeutic areas, including the development of novel drugs and diagnostic agents.

The chemical formula of 2,5-Difluoromandelic acid is C₉H₆F₂O₃, and it features a benzene ring substituted with two fluorine atoms at the 2 and 5 positions, along with a carboxylic acid group. This specific arrangement of functional groups imparts unique physical and chemical properties to the molecule, making it an interesting subject for both academic and industrial research.

In recent years, the study of fluorinated compounds has seen a surge in interest due to their favorable pharmacological properties. Fluorine atoms can significantly influence the lipophilicity, metabolic stability, and binding affinity of molecules, which are crucial factors in drug design. 2,5-Difluoromandelic acid is no exception; its fluorine substituents enhance its ability to interact with biological targets, potentially leading to improved therapeutic outcomes.

The synthesis of 2,5-Difluoromandelic acid has been extensively studied and optimized. One common synthetic route involves the reaction of 2,5-difluorobenzaldehyde with an appropriate carboxylic acid derivative under controlled conditions. This method has been refined to achieve high yields and purity, making it suitable for large-scale production. The robustness and reproducibility of this synthetic pathway have contributed to the widespread availability of 2,5-Difluoromandelic acid for research purposes.

In the realm of medicinal chemistry, 2,5-Difluoromandelic acid has shown promise as a lead compound for the development of new drugs. Its ability to modulate specific biological pathways has been explored in various preclinical studies. For instance, recent research has demonstrated that derivatives of 2,5-Difluoromandelic acid exhibit potent anti-inflammatory and anti-cancer activities. These findings suggest that further investigation into the pharmacological properties of this compound could yield valuable therapeutic agents.

Beyond its potential as a drug candidate, 2,5-Difluoromandelic acid has also found applications in the development of diagnostic tools. The unique electronic properties of fluorine atoms make this compound suitable for use in imaging techniques such as positron emission tomography (PET). By incorporating 2,5-Difluoromandelic acid into imaging agents, researchers can achieve enhanced contrast and specificity in medical imaging studies.

The safety profile of 2,5-Difluoromandelic acid is another important aspect that has been thoroughly evaluated. Preclinical toxicology studies have indicated that this compound exhibits low toxicity at relevant concentrations. However, as with any chemical compound used in pharmaceutical research, ongoing safety assessments are essential to ensure its safe use in clinical settings.

In conclusion, 2,5-Difluoromandelic acid (CAS No. 207853-61-0) is a multifaceted compound with significant potential in both medicinal chemistry and diagnostic applications. Its unique molecular structure and favorable pharmacological properties make it an attractive candidate for further research and development. As ongoing studies continue to uncover new insights into its behavior and applications, the future prospects for this compound appear promising.

• 375369-29-2(2,4,5-trifluoromandelic acid)
• 32222-48-3((R)-2-Fluoromandelic acid)
• 389-31-1(2-Fluoromandelic acid)
• 132741-30-1(2,4-Difluoromandelic acid)
• 207974-19-4(2-(2,3-difluorophenyl)-2-hydroxyacetic acid)
• 207981-50-8(2,6-difluoromandelic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)